On October 23, in collaboration with Union Laiya and East Hospital, successfully held an academic salon on industry-university-research cooperation for innovative drugs. They had the honor of inviting the original inventor of the BOIN design (the first innovative Phase I clinical study design invented by a Chinese professor and certified by the U.S. FDA)

On October 27, UnionClin, in collaboration with Hangzhou Biopharma Town, Hongren Pharmaceutical, and Hangzhou HDXX, invited clinical medical experts, experienced audit mentors, outstanding industry enterprises, and professional partners to gather in Hangzhou. Focusing on the challenges throughout the entire process from new drug development to market launch, they engaged in brainstorming through practical case studies, bringing brilliant and insightful interpretations.

On June 18, 2023, hosted by UnionClin and co-organized with Genhouse and Taizhou Enze Medical Center, the thematic salon titled "Challenges and Responses Faced in Early Clinical Studies of New Oncology Drugs" was successfully held at Taizhou Hospital.

To thoroughly implement the spirit of the high-quality development meetings at the provincial, municipal, and district levels, and focus on the goal of strengthening the biopharmaceutical industry chain within the district, Guangzhou Development District Industry Fund Investment Group Co., Ltd.

On May 10, 2023, the thematic salon "Clinical Studies, Efficiency First"—Biomatrix Medicine Talk, co-hosted by UnionClin and Biomatrix, concluded successfully in Nanjing.

From April 7 to 9, 2023, the China Innovative Drug (Device) Medical Conference and CMAC Annual Meeting were successfully held at the Suzhou International Expo Center.